JANE HOLMES-WALKER

1.2k total citations · 1 hit paper
7 papers, 958 citations indexed

About

JANE HOLMES-WALKER is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Genetics. According to data from OpenAlex, JANE HOLMES-WALKER has authored 7 papers receiving a total of 958 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Endocrinology, Diabetes and Metabolism, 3 papers in Molecular Biology and 2 papers in Genetics. Recurrent topics in JANE HOLMES-WALKER's work include Diabetes Management and Research (3 papers), Diabetes Treatment and Management (2 papers) and Diabetes and associated disorders (1 paper). JANE HOLMES-WALKER is often cited by papers focused on Diabetes Management and Research (3 papers), Diabetes Treatment and Management (2 papers) and Diabetes and associated disorders (1 paper). JANE HOLMES-WALKER collaborates with scholars based in Australia and United Kingdom. JANE HOLMES-WALKER's co-authors include Rooshdiya Z. Karim, Christopher Liddle, Caroline Fung, Shehan Abeygunasekera, Martin Weltman, Rita Lin, Dev Samarasinghe, Shivakumar Chitturi, Jacob George and Jason M. Hui and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and Diabetes.

In The Last Decade

JANE HOLMES-WALKER

6 papers receiving 933 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome

2002 936 citations Shivakumar Chitturi, Shehan Abeygunasekera et al. Hepatology profile →

Peers

Countries citing papers authored by JANE HOLMES-WALKER

Since Specialization

Citations

This map shows the geographic impact of JANE HOLMES-WALKER's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JANE HOLMES-WALKER with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JANE HOLMES-WALKER more than expected).

Fields of papers citing papers by JANE HOLMES-WALKER

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by JANE HOLMES-WALKER. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JANE HOLMES-WALKER. The network helps show where JANE HOLMES-WALKER may publish in the future.

Co-authorship network of co-authors of JANE HOLMES-WALKER

This figure shows the co-authorship network connecting the top 25 collaborators of JANE HOLMES-WALKER. A scholar is included among the top collaborators of JANE HOLMES-WALKER based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with JANE HOLMES-WALKER. JANE HOLMES-WALKER is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

#	Work	Indexed citations
1	Reducing cardiometabolic risk with semaglutide in type 1 diabetes (RESET1): Study protocol of a phase 2 double‐blinded randomised placebo‐controlled trial 2024 ·Diabetic Medicine ·Ruth Frampton, (unknown), Samantha Hocking, JANE HOLMES-WALKER, (unknown), Jerry R. Greenfield	6
2	Sexual identity in congenital adrenal hyperplasia 2020 ·Journal of Paediatrics and Child Health ·(unknown), JANE HOLMES-WALKER, Namson S. Lau, (unknown), Gail Anderson, Michael Kohn, Simon Clarke	1
3	301-OR: The Impact of Continuous Glucose Monitoring in Youth with Type 1 Diabetes, Aged 16-21 2019 ·Diabetes ·(unknown), JANE HOLMES-WALKER, Kaye Farrell	1
4	24-Hour Holter Monitor Assessment of Heart Rate Variability Across the Spectrum of Diabetes 2018 ·Heart Lung and Circulation ·(unknown), Patricia F Anderson, JANE HOLMES-WALKER, (unknown), James J.H. Chong	0
5	A Mobile Phone and Web-Based Intervention for Improving Mental Well-Being in Young People With Type 1 Diabetes: Design of a Randomized Controlled Trial 2015 ·SHILAP Revista de lepidopterología ·Janine Clarke, (unknown), Charles F. Verge, JANE HOLMES-WALKER, Lesley V. Campbell, Kay Wilhelm, Judith Proudfoot	12
6	NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome breakdown → 2002 ·Hepatology ·Shivakumar Chitturi, Shehan Abeygunasekera, Geoffrey C. Farrell, JANE HOLMES-WALKER, Jason M. Hui, Caroline Fung, Rooshdiya Z. Karim, Rita Lin, Dev Samarasinghe, Christopher Liddle, Martin Weltman, Jacob George	936
7	Effects of calcium and exercise on bone mineral density in premenopausal women with osteoporosis 1995 ·Current Opinion in Obstetrics & Gynecology ·JANE HOLMES-WALKER, Gordana M. Prelević, Howard S. Jacobs	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact